Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT05848687
PHASE1/PHASE2

TINI 2: Total Therapy for Infants With Acute Lymphoblastic Leukemia II

Sponsor: Tanja Andrea Gruber

View on ClinicalTrials.gov

Summary

The purpose of this study is to improve upon the TINI study treatment. The study will test the ability of a type of immunotherapy called blinatumomab to clear persistent leukemia. Blinatumomab targets CD19 which is located on the leukemia cells outer membrane.

Key Details

Gender

All

Age Range

Any - 1 Year

Study Type

INTERVENTIONAL

Enrollment

90

Start Date

2023-11-03

Completion Date

2033-12

Last Updated

2026-01-13

Healthy Volunteers

No

Interventions

DRUG

Dexamethasone

Given orally (PO) or naso-gastrically (NG) or intravenously (IV).

DRUG

Mitoxantrone

Given IV

DRUG

PEG asparaginase

Given IV

DRUG

Bortezomib

Given IV

DRUG

Vorinostat

Taken PO or NG

DRUG

Mercaptopurine

Given PO or NG.

DRUG

Methotrexate

Given IV, IM or PO

DRUG

Blinatumomab

Will be administered at 15 mcg/m2/day for 28 days following induction and reinduction

DRUG

Ziftomenib

3+3 dose escalation will be done. Dose level 1 will start at 75% of the adult recommended phase two dosing which has been established in phase I studies. Based on tolerability, we will either de-escalate to 50% RP2D (dose level -1) or escalate to 100% RP2D

Locations (25)

Phoenix Children's Hospital

Phoenix, Arizona, United States

Arkansas Children's Hospital

Little Rock, Arkansas, United States

Children's Hospital Los Angeles

Los Angeles, California, United States

Valley Children's Hospital

Madera, California, United States

Children's Hospital of Orange County

Orange, California, United States

Stanford University

Palo Alto, California, United States

Rady Children's Hospital San Diego

San Diego, California, United States

Arnold Palmer Hospital for Children

Orlando, Florida, United States

Children's Hospital of Minnesota

Minneapolis, Minnesota, United States

Memorial Sloan Kettering Cancer Center

New York, New York, United States

Novant Health - Hemby Children's Hospital

Charlotte, North Carolina, United States

Doernbecher Children's Hospital

Portland, Oregon, United States

Penn State Milton S Hershey Medical Center

Hershey, Pennsylvania, United States

MD Anderson

Houston, Texas, United States

University of Texas Health Science Center San Antonio

San Antonio, Texas, United States

University of Utah Huntsman Cancer Institute

Salt Lake City, Utah, United States

Children's Hospital of The King's Daughters

Norfolk, Virginia, United States

University of Wisconsin Carbone Cancer Center

Madison, Wisconsin, United States

Alberta Children's Hospital

Calgary, Alberta, Canada

Stollery Children's Hospital

Edmonton, Alberta, Canada

BC Children's Hospital

Vancouver, British Columbia, Canada

McMaster Children's Hospital

Hamilton, Ontario, Canada

CHU Sainte-Justine

Montreal, Quebec, Canada

Montreal Children's Hospital

Montreal, Quebec, Canada

Chu De Quebec

Québec, Quebec, Canada